Lene Thorsen1, Kerry S Courneya, Clare Stevinson, Sophie D Fosså. 1. Department of Clinical Cancer Research, Division of Cancer Medicine and Radiotherapy, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway. lene.thorsen@radiumhospitalet.no
Abstract
INTRODUCTION: We reviewed physical activity (PA) studies in prostate cancer (PC) survivors investigating (a) the effects of PA on health outcomes, (b) the prevalence of PA, and (c) the determinants of PA. MATERIALS AND METHODS: A systematic search of the literature identified nine studies on the outcomes of PA, six studies on the prevalence of PA, and four studies on the determinants of PA in PC survivors. RESULTS: Results showed promising effects of PA on muscular fitness, physical functioning, fatigue, and health-related quality of life. The prevalence of PA varied widely from <30% to >70%, depending on the type of measure used. PA in PC survivors was predicted by motivational variables such as intentions, perceived behavioral control, and subjective norms. CONCLUSION: Although preliminary research is promising, there remains a significant amount of research to be done on the role of PA in PC survivors. Moreover, future research would benefit from larger samples using randomized controlled trial methodology.
INTRODUCTION: We reviewed physical activity (PA) studies in prostate cancer (PC) survivors investigating (a) the effects of PA on health outcomes, (b) the prevalence of PA, and (c) the determinants of PA. MATERIALS AND METHODS: A systematic search of the literature identified nine studies on the outcomes of PA, six studies on the prevalence of PA, and four studies on the determinants of PA in PC survivors. RESULTS: Results showed promising effects of PA on muscular fitness, physical functioning, fatigue, and health-related quality of life. The prevalence of PA varied widely from <30% to >70%, depending on the type of measure used. PA in PC survivors was predicted by motivational variables such as intentions, perceived behavioral control, and subjective norms. CONCLUSION: Although preliminary research is promising, there remains a significant amount of research to be done on the role of PA in PC survivors. Moreover, future research would benefit from larger samples using randomized controlled trial methodology.
Authors: William W Bassett; Matthew R Cooperberg; Natalia Sadetsky; Stefanie Silva; Janeen DuChane; David J Pasta; June M Chan; Jason W Anast; Peter R Carroll; Christopher J Kane Journal: Urology Date: 2005-11 Impact factor: 2.649
Authors: J C Smith; S Bennett; L M Evans; H G Kynaston; M Parmar; M D Mason; J R Cockcroft; M F Scanlon; J S Davies Journal: J Clin Endocrinol Metab Date: 2001-09 Impact factor: 5.958
Authors: Vicki S Conn; Adam R Hafdahl; Davina C Porock; Roxanne McDaniel; Paul J Nielsen Journal: Support Care Cancer Date: 2006-01-31 Impact factor: 3.603
Authors: Terrence H Diamond; Joseph Bucci; John H Kersley; Peter Aslan; William B Lynch; Carl Bryant Journal: J Urol Date: 2004-08 Impact factor: 7.450
Authors: Shabbir M H Alibhai; Sara O'Neill; Karla Fisher-Schlombs; Henriette Breunis; Joseph M Brandwein; Narhari Timilshina; George A Tomlinson; Heidi D Klepin; S Nicole Culos-Reed Journal: Leuk Res Date: 2012-06-21 Impact factor: 3.156
Authors: Siobhan M Phillips; Meir J Stampfer; June M Chan; Edward L Giovannucci; Stacey A Kenfield Journal: J Cancer Surviv Date: 2015-04-16 Impact factor: 4.442
Authors: Dori Rosenberg; Elyse A Kadokura; Erin D Bouldin; Christina E Miyawaki; Celestia S Higano; Andrea L Hartzler Journal: AMIA Annu Symp Proc Date: 2017-02-10
Authors: Maria Pisu; Wendy Demark-Wahnefried; Kelly M Kenzik; Robert A Oster; Chee Paul Lin; Sharon Manne; Ronald Alvarez; Michelle Y Martin Journal: J Cancer Surviv Date: 2017-01-09 Impact factor: 4.442